Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate
Pricing Report NDC 0115-1329-01

Latest NADAC: $1.78648 per EA · Effective Aug 22, 2018 · Est. package price $178.65 (100 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 0115-1329-01) is $1.78648 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 22, 2018.

As a provided by Global Pharmaceuticals, Division Of Impax Laboratories Inc., this medication is distributed in a 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.78648
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Aug 22, 2018
Billable Units
100 EA
Estimated Package Price
$178.65
Data Status
As of Sep 05, 2018
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0115-1329-01
Description
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $1.78648 to $3.94868 per EA. Over this 4 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.7865 - $3.9487
Market Volatility
121.03% Variance
Latest Trend
13.94%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 22, 2018 $1.78648 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 18, 2018 $2.07584 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 20, 2018 $2.04249 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 23, 2018 $1.94714 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 18, 2018 $2.00440 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 21, 2018 $2.08143 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 21, 2018 $2.16943 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 17, 2018 $1.96700 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 20, 2017 $2.28196 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 22, 2017 $2.18637 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 18, 2017 $2.34290 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 20, 2017 $2.64572 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026